Back to top

medical-devices: Archive

Zacks Equity Research

InspireMD Launches CGuard Prime Carotid Stent System in the U.S.

NSPR unveils FDA-approved CGuard Prime in the United States, targeting safer carotid procedures and stroke prevention.

CORNegative Net Change NSPRNegative Net Change ITGRNegative Net Change HIMSNegative Net Change

Urmimala Biswas

Smart Money Going in Senior Health: Key Stocks in Elderly Care

RHHBY, NVO, EW and SYK are ramping up senior care innovation as aging populations reshape global healthcare demand.

ABTNegative Net Change RHHBYNegative Net Change NVONegative Net Change MDTPositive Net Change SYKNegative Net Change EWNegative Net Change

Zacks Equity Research

Here's Why You Should Add Cencora Stock to Your Portfolio Now

COR gains on strong GLP-1 and specialty drug growth, but margin pressure and fierce competition pose ongoing risks.

CVSNegative Net Change CORNegative Net Change CODXNegative Net Change WGSNegative Net Change

Indrajit Bandyopadhyay

OptimizeRx Bets on AI and Workflow Integration: Will This Pay Off?

OPRX doubles down on AI and subscriptions, but margin mix and retention risks loom over its platform transformation.

OPRXNegative Net Change HSTMNegative Net Change DOCSPositive Net Change

Sridatri Sarkar

3 AI-Driven Medical Device Stocks to Watch in 2025

BSX, JNJ and GEHC are leveraging AI to boost device performance, diagnostics and surgical precision in 2025.

BSXNegative Net Change JNJNegative Net Change ISRGNegative Net Change NVDAPositive Net Change GEHCNegative Net Change

Zacks Equity Research

Reasons to Add Fresenius Medical Stock to Your Portfolio Now

FMS continues to gain traction on the back of acquisitions & partnerships. A tough regulatory environment raises concerns.

FMSNegative Net Change CORNegative Net Change ITGRNegative Net Change HIMSNegative Net Change

Moumi Mondal

Hologic's GYN Surgical Dominance: What's Powering the Road Ahead?

HOLX's GYN Surgical arm gains momentum with Fluent Pro, global expansion and strategic acquisitions fueling growth.

JNJNegative Net Change MDTPositive Net Change HOLXNegative Net Change

Zacks Equity Research

Here's Why You Should Retain CONMED Stock in Your Portfolio for Now

CNMD stock rides high on strong recurring revenues, margin gains, and surgical product growth despite supply and cybersecurity challenges.

CNMDNegative Net Change CVSNegative Net Change CORNegative Net Change WGSNegative Net Change

Zacks Equity Research

Should You Continue to Hold STERIS Stock in Your Portfolio Now?

STE rides on strong Healthcare and AST growth, but macro pressures and customer consolidation cloud its outlook.

CAHNegative Net Change CORNegative Net Change STENegative Net Change PAHCNegative Net Change

Mark Vickery

Top Research Reports for SAP, Novo Nordisk & Thermo Fisher

SAP gains on cloud strength, NVO faces obesity setbacks, and TMO leans on AI and innovation amid macro headwinds.

NVONegative Net Change TMOPositive Net Change SAPNegative Net Change PSXNegative Net Change CGNegative Net Change HUBSNegative Net Change HURCNegative Net Change FONRNegative Net Change

Zacks Equity Research

AMN Stock Gains Post Latest Deals With symplr to Boost Operations

AMN Healthcare sells Smart Square to symplr for $75 million and forms a new technology partnership aimed at boosting scheduling efficiency.

BSXNegative Net Change CORNegative Net Change AMNNegative Net Change ITGRNegative Net Change

Zacks Equity Research

Here's Why You Should Add PacBio Stock to Your Portfolio Now

PACB benefits from strong first-quarter results, product innovation, and cost cuts to offset macroeconomic concerns and drive 2025 growth.

CORNegative Net Change PACBNegative Net Change ITGRNegative Net Change HIMSNegative Net Change

Harshit Gupta

Veeva Expands Market Reach Through Targeted Strategic Partnerships

VEEV gains momentum in 2025 with strategic partnerships fueling growth in AI, clinical research, and compliance.

ORCLNegative Net Change VEEVNegative Net Change IQVNegative Net Change

Zacks Equity Research

Should You Continue to Hold Thermo Fisher Stock in Your Portfolio Now?

TMO's growth via acquisitions and product launches is strong, but macro pressures and FX headwinds cloud the outlook.

TMOPositive Net Change CAHNegative Net Change CORNegative Net Change PAHCNegative Net Change

Zacks Equity Research

Glaukos Ramps Up iDose TR, Battles Legacy and Reimbursement Risks

GKOS posts record Q1 on iDose TR strength, but reimbursement hurdles and legacy declines may hurt its near-term outlook.

JNJNegative Net Change ALCNegative Net Change GKOSNegative Net Change SGHTNegative Net Change

Moumi Mondal

Is CVS Moving Closer to Reaching Its Long-Term Low 3X Leverage Goal?

CVS Health inches closer to its long-term leverage target, helped by Aetna margin recovery and disciplined cash use.

UNHPositive Net Change CINegative Net Change CVSNegative Net Change

Zacks Equity Research

Is the Options Market Predicting a Spike in AdaptHealth Stock?

Investors need to pay close attention to AHCO stock based on the movements in the options market lately.

AHCONegative Net Change